Preclinical Imaging Market Size To Expand at a Notable CAGR Of 3.20% During 2023- 2030

Pune, India, February, 2022/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Preclinical Imaging Market.

Preclinical Imaging Market Highlights

The global Preclinical Imaging Market is accounted to register a CAGR of 3.20% during the forecast period and is estimated to reach USD 5.48 billion by 2030.

The preclinical imaging market refers to the use of imaging technologies and modalities for conducting research and experiments on animal models in preclinical stages of drug development. Preclinical imaging enables researchers to visualize and study the anatomy, physiology, and molecular processes in animals, providing valuable insights into disease mechanisms, drug efficacy, and toxicity.

Segment Analysis

The global Preclinical Imaging Market has been segmented based on Product, and Reagent.

The market segments of Preclinical Imaging, based on Product, includes optical imaging, nuclear imaging, micro-MRI, micro-ultrasound, micro-CT, and photoacoustic imaging systems. The optical imaging segment held the majority share in 2022 in the Preclinical Imaging market data. This is due to their widespread use in projects to discover new drugs and image small animals. During the forecast period the Micro-ultrasound segment is expected to grow at the fastest CAGR during the forecast period. Micro-ultrasound, a scaled-down variation of ultrasound, has a wider range of uses, particularly in studies involving small animal models. These more compact imaging methods increase the effectiveness of the methods.

The Preclinical Imaging market data, based on reagents, include optical, nuclear, CT contrast agents, and MRI contrast agents. The optical segment dominated the market revenue of Preclinical Imaging in 2022. The growing use of optical imaging is furling the demand for optical reagents, given that all imaging procedures use these products extensively. Therefore, buying these products is common. CT contrast agents are projected to be the faster-growing segment during the forecast period.

Regional Analysis

The global Preclinical Imaging Market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Preclinical Imaging market accounted for USD 36.4 billion in 2022, with a share of around 45.80%, and is expected to exhibit a significant CAGR growth during the study period. Higher adoption rates of technologically advanced devices in the area, developed infrastructure, and a large number of preclinical projects. The region's greater adoption of technologically advanced devices, the accessibility of skilled professionals, the volume of preclinical projects, and so forth. New clinical research and development projects are also being encouraged by government initiatives in this region

Europe Preclinical Imaging market accounts for the second-largest market share. In-vivo imaging systems are becoming more widely used in Preclinical research due to the growing number of clinical research organizations (CROs) and pharmaceutical companies, further accelerating the growth of this market. Moreover, the UK market of preclinical Imaging held the largest market share, and the Germany market of preclinical Imaging was the fastest-growing market in the region.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Preclinical Imaging Market Research Report

Asia Pacific Preclinical Imaging Market is expected to grow at the fastest CAGR from 2022 to 2030. The region is becoming more appealing for preclinical research studies due to low research costs, laxer regulatory requirements, and increased government funding for developing the research and development sector in the respective countries. Moreover, the factors attributing to the market development include expanded public-private initiatives, innovative advances in molecular imaging, and expanded market interest in non-intrusive small animal imaging methods. Further, the China market of preclinical Imaging held the largest market share, and the India market of preclinical Imaging was the fastest-growing region.

Key Findings of the Study

• The global Preclinical Imaging Market is expected to reach USD 5.48 billion by 2030, at a CAGR of 3.20% during the forecast period.


• Asia Pacific Preclinical Imaging Market is expected to grow at the fastest CAGR from 2022 to 2030. The region is becoming more appealing for preclinical research studies due to low research costs, laxer regulatory requirements, and increased government funding for developing the research and development sector in the respective countries.


• The market segments of Preclinical Imaging, based on Product, includes optical imaging, nuclear imaging, micro-MRI, micro-ultrasound, micro-CT, and photoacoustic imaging systems. The optical imaging segment held the majority share in 2022 in the Preclinical Imaging market data.


• Bruker Corporation (US), MR Solutions (UK), PerkinElmer (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), Miltenyi Biotec GmbH (Germany), LI-COR Inc. (US), Aspect Imaging (Israel), and Trifoil Imaging (US)